Publication | Closed Access

Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy

Surgical OncologyPlatinum-based Doublet ChemotherapyMedicinePathologyBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung CancerCancer Research